Recombinant urate oxidase (SR 29142) to prevent hyperuricaemia during chemotherapy for haematological malignancies.

Recombinant urate oxidase (SR 29142) to prevent hyperuricaemia during chemotherapy for haematological malignancies.

Dettagli Bibliografici
Autori principali:	Littlewood, T, Schuh, A, Haynes, SR
Natura:	Journal article
Pubblicazione:	1998

Documenti analoghi

Enhanced production of extracellular urate oxidase by Aspergillus Flavus
di: Wan Ruhayu, Wan Ramli
Pubblicazione: (2013)

Immunotherapy and immunomodulation for haematological malignancies
di: Mussai, F, et al.
Pubblicazione: (2012)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological malignancies (Review).
di: Wardrop, D, et al.
Pubblicazione: (2013)

The expression of phosphorylated KDR in haematological malignancies
di: Pillai, G, et al.
Pubblicazione: (2003)

Targeting translation factors in haematologic malignancies.
di: Lee, Janice Siu Hui.
Pubblicazione: (2011)

Bone marrow inflammation in haematological malignancies
di: de Jong, M, et al.
Pubblicazione: (2024)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
di: Desborough, M, et al.
Pubblicazione: (2016)

Gene silencing by DNA methylation in haematological malignancies.
di: Boultwood, J, et al.
Pubblicazione: (2007)

HDAC inhibitor-based therapies and haematological malignancy.
di: Stimson, L, et al.
Pubblicazione: (2009)

Risk factors for haemorrhage in patients with haematological malignancies
di: Estcourt, LJ
Pubblicazione: (2014)

Immunoglobulin replacement to prevent infections in people with haematological malignancies and haematopoietic stem cell transplantation (protocol)
di: Chai, KL, et al.
Pubblicazione: (2024)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
di: Estcourt, L, et al.
Pubblicazione: (2012)

Incidence of haematological malignancies by ethnic group in England, 2001-7
di: Shirley, M, et al.
Pubblicazione: (2013)

Platelet transfusions for patients with haematological malignancies: who needs them?
di: Estcourt, L, et al.
Pubblicazione: (2011)

Incidence of haematological malignancies by ethnic group in England, 2001-7.
di: Shirley, M, et al.
Pubblicazione: (2013)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
di: Estcourt, L, et al.
Pubblicazione: (2014)

Antiviral prophylaxis for varicella zoster in immunocompromised patients (excluding haematological malignancies)
di: Chang, C, et al.
Pubblicazione: (2009)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
di: Estcourt, L, et al.
Pubblicazione: (2015)

The role of chemotherapy in the nonsurgical management of malignant neuroendocrine tumours.
di: Kaltsas, G, et al.
Pubblicazione: (2001)

The role of chemotherapy management of malignant in the nonsurgical neuroendocrine tumours
di: Kaltsas, G, et al.
Pubblicazione: (2001)

Prophylactic platelet transfusions in patients with haematological malignancies – lessons from the TOPPS trial
di: Estcourt, L
Pubblicazione: (2016)

Intracranial hemorrhage in patients with haematological malignancy, a nested case-control study
di: Estcourt, L, et al.
Pubblicazione: (2017)

Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stemcell support (Review)
di: Estcourt, L, et al.
Pubblicazione: (2017)

Restrictive versus liberal red blood cell transfusion strategies for patients with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support
di: Butler, C, et al.
Pubblicazione: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
di: Estcourt, L, et al.
Pubblicazione: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
di: Estcourt, L, et al.
Pubblicazione: (2014)

Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study
di: Kroll, M, et al.
Pubblicazione: (2012)

A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies
di: Liggins, A, et al.
Pubblicazione: (2010)

Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study.
di: Murphy, F, et al.
Pubblicazione: (2013)

A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies.
di: Liggins, A, et al.
Pubblicazione: (2010)

Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study.
di: Murphy, F, et al.
Pubblicazione: (2013)

Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study.
di: Kroll, M, et al.
Pubblicazione: (2012)

From genomics to targeted treatment in haematological malignancies: a focus on acute myeloid leukaemia
di: Jakobsen, N, et al.
Pubblicazione: (2018)

The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors.
di: Kaltsas, G, et al.
Pubblicazione: (1998)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
di: Estcourt, L, et al.
Pubblicazione: (2014)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
di: Crighton, GL, et al.
Pubblicazione: (2015)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
di: Estcourt, L, et al.
Pubblicazione: (2016)

Epigenome-wide association study of serum urate reveals insights into urate co-regulation and the SLC2A9 locus
di: Tin, Adrienne, et al.
Pubblicazione: (2022)

Transfusions in people with haematological malignancies – Results of a repeat UK national comparative audit with improvement in practice
di: Estcourt, L, et al.
Pubblicazione: (2018)

Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.
di: Stanworth, S, et al.
Pubblicazione: (2006)